News

Cupron® Performance Additives Unveils Groundbreaking “Clear” Liquid Copper Platform for Sustainable Microbial Control Applications

Cupron Performance Additives (Cupron) today announced the launch of Cupron Clear™ — a revolutionary new liquid microbial copper platform. Cupron Clear™ is a transparent, stable, and highly efficacious liquid form of copper, designed for broad use across polymers and liquids. This new breakthrough delivers unmatched microbial control while exceeding modern standards for sustainability, economics, and safety.

Cupron Clear™ reinvents the chemistry of copper-based additives for liquid products, delivering over a hundred times the effectiveness of conventional copper solutions. With its innovative clear liquid format, Cupron Clear™ out-performs incumbent additives such as QUATs and Isothiazolinones, many of which are facing growing regulatory pressure. Cupron Clear™ sets a new standard for broad-spectrum efficacy against microorganisms. This next-generation technology provides end market and downstream users with a more sustainable, versatile, and high-performing copper-based biocide than ever before.

“This new liquid copper platform addresses the frustrations for so many different industries and dramatically expands the applications that can enjoy the benefits of Cupron innovations,” said Chris Andrews, CEO of Cupron. “It’s the direct result of focused R&D and our belief that economic, safer, sustainable technologies should replace legacy materials that no longer meet regulatory or performance standards.”

Representing a major leap forward in copper-based technologies, Cupron Clear™ is a first-to-market solution for personal care, hygiene, building & construction, textiles, plastics, paints and other coatings, adhesives, sealants, elastomers (C.A.S.E.) markets in need of the highest-performing form of cuprous copper in a colorless, liquid format.

“With the addition of Cupron Clear™ to the company’s product portfolio, we can now offer our partners unparalleled flexibility in manufacturing and application with a comprehensive suite of platforms across solid, dispersion and solution-based applications,” Andrews added.

In addition to securing patents and intellectual property rights across composition, process, and applications of Cupron Clear™, Cupron is already in discussion with global partners and distributors to deploy it across core markets.

Read more here.

Recent News

10/23/2026

PAK BioSolutions and iBET Advance Integrated Continuous AAV8 Purification

PAK BioSolutions today announced the publication of a peer-reviewed study on integrated, continuous purification of adeno-associated virus serotype 8 (AAV8) using the PAK PD™ Process Development Scale Continuous Purification System. Conducted in collaboration with iBET – Instituto de Biologia Experimental e Tecnológica, the study, “Streamlining AAV8 Purification with Cyclic Integrated Capture–Polishing Chromatography,” was published in …

10/22/2026

Lilly breaks ground in Richmond to expand American manufacturing of next-generation cancer medicines, advancing its build-out of 10 new U.S. sites since 2020

Eli Lilly and Company (NYSE: LLY) broke ground today on a new $5 billion manufacturing facility just west of Richmond, Virginia, in Goochland County, one of 10 new U.S. manufacturing sites announced since 2020 and one of five among them that will produce active pharmaceutical ingredients (API). As part of the company’s more than $50 …

10/21/2026

United Therapeutics Expands Organ Manufacturing Capabilities with Opening of Third Designated Pathogen-Free Xenograft Production Facility

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced the opening of its third Designated Pathogen-Free (DPF) facility, The Dr. Bartley P. Griffith and Dr. Robert A. Montgomery Xenograft Production Facility, in Houston, Texas. United Therapeutics opened its first DPF facility in Christiansburg, Va. in 2024 to produce xenografts for ongoing clinical trials. …